Diffuse large B-cell lymphoma in very elderly patients older than 80 years: A multicenter retrospective analysis of clinical characteristics, treatment patterns, and outcome—KCSG LY16-01.
Jung Hye Choi(Hanyang University Guri Hospital), Yun Hwa Jung(The Catholic University of Korea Yeouido St. Mary's Hospital), Seok‐Hyun Kim(Samsung Changwon Hospital), Jung Hye Kwon(Hallym University), Jun Ho Yi(Chung-Ang University), Hyeok Shim(Wonkwang University), Sung Ae Koh(Yeungnam University), Der-Sheng Sun(The Catholic University of Korea Uijeongbu St. Mary's Hospital), So Young Chong(CHA University Bundang Medical Center), Hyo Jung Kim(Yonsei University), Tae Min Kim(Seoul National University Hospital), Seung‐Hyun Nam(Kyung Hee University Hospital at Gangdong), Hye Jin Kang(Korea Institute of Radiological and Medical Sciences), Jaejoon Han(Seoul National University Hospital), Soonil Lee(Dankook University Hospital), Young Jin Yuh(Inje University Sanggye Paik Hospital), Soon-Nam Lee(Ewha Womans University Medical Center), Byeong Bae Park(Hanyang University Guri Hospital), Jong‐Youl Jin(The Catholic University of Korea Bucheon St. Mary's Hospital)
Cited by 0
Related Papers
Cytokinin-mediated control of leaf longevity by AHK3 through phosphorylation of ARR2 in <i>Arabidopsis</i>
|Proceedings of the National Academy of Sciences|2006|430
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With <i>EGFR</i> Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer
|JAMA Oncology|2021|289
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
|Leukemia|2024|132
Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage
|Free Radical Biology and Medicine|2007|100
Transforming Growth Factor-β1 Is a Molecular Target for the Peroxisome Proliferator-Activated Receptor δ
|Circulation Research|2007|77